Admission to Trading

Summary by AI BETAClose X

Derwent London plc announced the admission to trading of 6,193 ordinary shares of 5p each on the London Stock Exchange, pursuant to their allotment under the Derwent London Performance Share Plan 2014. This issuance brings the total number of shares in issue and admitted to trading to 112,297,122. This notification covers the period from March 10, 2026, to April 10, 2026.

Disclaimer*

Derwent London PLC
10 April 2026
 

For immediate release

 

 

Derwent London plc
 ("Derwent London"/"the Company")

 

Admission to Trading

 

 

In accordance with the Financial Conduct Authority's Prospectus Rules: Admission to Trading on a Regulated Market (PRM) sourcebook 1.6.4R, the Company notifies the market that the following shares have been admitted to trading pursuant to their allotment under the Derwent London Performance Share Plan 2014 as follows:

 

 

 

Issuer name:

 

 

Derwent London plc

 

Issuer LEI:

213800BXKQ9KZNUR1M61

Regulated market on which the shares have been admitted to trading:

London Stock Exchange (XLON)

Description and type of financial instrument:

 

Identification code:

Ordinary shares of 5p in Derwent London plc

 

GB0002652740

Number of shares issued and admitted to trading during period of return (new shares are fungible with existing shares)

6,193

Total number of shares in issue and admitted to trading following issuance:

112,297,122

Coverage of notification:

10 March 2026 - 10 April 2026

 

 

Enquiries:

D A Lawler

Company Secretary

 

10 April 2026

 

020 7659 3000

www.derwentlondon.com

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100